<ѻý>Older Men Still Overscreened for Prostate Cancer, Survey Saysѻý> PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
<ѻý>FDA Greenlights New First-Line Regimen in Bladder Cancerѻý> Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<ѻý>Post-Immunotherapy Combo Promising in Advanced RCCѻý> Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<ѻý>Neuromodulation of the Peroneal Nerve Safe for Overactive Bladderѻý> Was also as effective as solifenacin in the majority of assessed efficacy endpoints Mar 24, 2023
<ѻý>Treating Gender Nonconforming Youth Goes Beyond the Physicalѻý> We must approach care for every patient from the lens of treating the entire individual Mar 15, 2023
<ѻý>Gender-Affirming Surgery Gets a Boost After California Law Kicked Inѻý> Nondiscrimination law bars insurers from limiting benefits based on gender identity, expression Mar 14, 2023
<ѻý>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancersѻý> ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<ѻý>A Surge in Vasectomies: Sustaining the Demandѻý> To increase participation, let's reduce the points of friction Mar 13, 2023
<ѻý>Daily Thiazide No Help in Preventing Recurrent Kidney Stonesѻý> Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
<ѻý>Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subsetѻý> Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
<ѻý>FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuriaѻý> Non-immunosuppressive therapy led to 50% reduction in proteinuria Feb 21, 2023
<ѻý>Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancerѻý> KEYNOTE-057 trial results suggest DFS benefit for patient population with unmet need Feb 19, 2023
<ѻý>Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomyѻý> But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
<ѻý>Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPCѻý> Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
<ѻý>Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancerѻý> Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
<ѻý>Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancerѻý> Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
<ѻý>If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer?ѻý> Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
<ѻý>Hormone Infusion Shows Promise for Low Sexual Desireѻý> Pair of trials demonstrated efficacy in hypoactive sexual desire disorder Feb 03, 2023
<ѻý>Gender-Affirming Hormones Boost Mental Health for Transgender Youthѻý> Gains seen in appearance congruence paired with drops in depression and anxiety, study showed Jan 18, 2023
<ѻý>Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancerѻý> Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
<ѻý>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastasesѻý> More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<ѻý>5-ARIs Not Linked to Risk of Dementia Over the Long Termѻý> However, finasteride and dutasteride were associated with an increased risk of depression Dec 22, 2022
<ѻý>One Doc's Win for Trans Youth Healthcare in Texasѻý> A Dallas endocrinologist can continue to provide hormone therapy and puberty blockers Dec 16, 2022
<ѻý>FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancerѻý> Half of patients achieved complete responses with adenoviral vector-based product Dec 16, 2022
<ѻý>MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosisѻý> Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
<ѻý>Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?ѻý> Barriers exist in identifying risk, but strategies are available Dec 06, 2022
<ѻý>Aging U.S. Population a Challenge for Oncologistsѻý> Older patients will have different care goals, preferences, geriatric oncologist says Dec 05, 2022
<ѻý>A Dangerous Chilling Effect in Gender-Affirming Careѻý> Gender-affirming facilities must continue offering information and resources, despite threats Dec 03, 2022
<ѻý>To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urgesѻý> Overprescribing a continuing problem, Benjamin Davies tells urologists Dec 02, 2022
<ѻý>Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumorsѻý> Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
<ѻý>Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapseѻý> But patients with BCG-refractory disease may be better suited for cystectomy Dec 02, 2022
<ѻý>Overactive Bladder Linked to Multiple Unmet Socioeconomic Needsѻý> Findings reinforce existing evidence, identify novel factors, suggest future research Dec 01, 2022
<ѻý>Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancerѻý> Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
<ѻý>Exercise During Chemo Shows Benefits for Cardiorespiratory Fitnessѻý> However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
<ѻý>Youth With Gender Dysphoria Hospitalized for Suicidal Ideation Far More Oftenѻý> Inpatient setting offers unique opportunity to provide gender-affirming care, researchers say Nov 16, 2022
<ѻý>Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortalityѻý> Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
<ѻý>Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancerѻý> Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
<ѻý>Florida Medical Boards Ban Gender-Affirming Care for Kidsѻý> First state to limit care for trans youth through medical board action Nov 07, 2022
<ѻý>Testosterone Tied to Sustained Weight Loss in Men With Hypogonadism and Obesityѻý> Small data set finds large weight reductions over time Nov 04, 2022
<ѻý>Treatment De-Escalation Shows Promise in Testicular Cancerѻý> Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022